P149 Effect of macitentan on pulmonary arterial hypertension-related hospitalisations: results from the randomised controlled SERAPHIN trial

G Coghlan; RN Channick; LJ Rubin; N Galiè; L Perchenet; G Simonneau

doi:10.1136/thoraxjnl-2013-204457.299

Article info

Pulmonary hypertension: mechanisms and treatment

P149 Effect of macitentan on pulmonary arterial hypertension-related hospitalisations: results from the randomised controlled SERAPHIN trial

Free

Authors

G Coghlan 1Royal Free Hospital, London, UK PubMed articles Google scholar articles
RN Channick 2Massachusetts General Hospital, Boston, USA PubMed articles Google scholar articles
LJ Rubin 3University of California, San Diego, USA PubMed articles Google scholar articles
N Galiè 4University of Bologna, Bologna, Italy PubMed articles Google scholar articles
L Perchenet 5Actelion Pharmaceuticals Ltd, Allschwil, Switzerland PubMed articles Google scholar articles
G Simonneau 6Hôpital Universitaire de Bicêtre, Le Kremlin-Bicêtre, France PubMed articles Google scholar articles

Citation

Coghlan G, Channick R, Rubin L, et al

P149 Effect of macitentan on pulmonary arterial hypertension-related hospitalisations: results from the randomised controlled SERAPHIN trial

Thorax 2013;68:A143.

Publication history

First published November 14, 2013.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password